The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
06 2021
Historique:
received: 12 11 2020
revised: 01 02 2021
accepted: 17 02 2021
pubmed: 29 3 2021
medline: 15 12 2021
entrez: 28 3 2021
Statut: ppublish

Résumé

The aim was to assess 3-year longitudinal data using 6MWT in 26 ambulant boys affected by DMD carrying nonsense mutations and to compare their results to other small mutations. We also wished to establish, within the nonsense mutations group, patterns of change according to several variables. Patients with nonsense mutations were categorized according to the stop codon type newly created by the mutation and also including the adjacent 5' (upstream) and 3' (downstream) nucleotides. No significant difference was found between nonsense mutations and other small mutations (p > 0.05) on the 6MWT. Within the nonsense mutations group, there was no difference in 6MWT when the patients were subdivided according to: Type of stop codon, frame status of exons involved, protein domain affected. In contrast, there was a difference when the stop codon together with the 3' adjacent nucleotide ("stop+4 model") was considered (p < 0.05) with patients with stop codon TGA and 3' adjacent nucleotide G (TGAG) having a more rapid decline. Our finding suggest that the stop+4 model may help in predicting functional changes. This data will be useful at the time of interpreting the long term follow up of patients treated with Ataluren that are becoming increasingly available.

Identifiants

pubmed: 33773883
pii: S0960-8966(21)00043-2
doi: 10.1016/j.nmd.2021.02.015
pii:
doi:

Substances chimiques

Codon, Nonsense 0
Dystrophin 0
Oxadiazoles 0
ataluren K16AME9I3V

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-488

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Claudia Brogna (C)

Pediatric Neurology, Università Cattolica del Sacro Cuore, Rome, Italy; Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, Rome 00152, Italy.

Giorgia Coratti (G)

Pediatric Neurology, Università Cattolica del Sacro Cuore, Rome, Italy; Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, Rome 00152, Italy.

Rachele Rossi (R)

Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Marcella Neri (M)

Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Sonia Messina (S)

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; Nemo SUD Clinical Center, University Hospital "G. Martino", Messina, Italy.

Adele D' Amico (A)

Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Claudio Bruno (C)

Center of Translational and Experimental Myology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Simona Lucibello (S)

Pediatric Neurology, Università Cattolica del Sacro Cuore, Rome, Italy; Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, Rome 00152, Italy.

Gianluca Vita (G)

Nemo SUD Clinical Center, University Hospital "G. Martino", Messina, Italy.

Angela Berardinelli (A)

Child Neurology and Psychiatry Unit, ''Casimiro Mondino'' Foundation, Pavia, Italy.

Francesca Magri (F)

Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico, Dino Ferrari Center, , University of Milan, Milan, Italy.

Federica Ricci (F)

Neuromuscular Center, AOU Città della Salute e della Scienza, University of Torino, Italy.

Marina Pedemonte (M)

Center of Translational and Experimental Myology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Tiziana Mongini (T)

Neuromuscular Center, AOU Città della Salute e della Scienza, University of Torino, Italy.

Roberta Battini (R)

Department of Developmental Neuroscience, Stella Maris Institute, Pisa, Italy; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Luca Bello (L)

Department of Neurosciences, University of Padua, Padua, Italy.

Elena Pegoraro (E)

Department of Neurosciences, University of Padua, Padua, Italy.

Giovanni Baranello (G)

Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Luisa Politano (L)

Cardiomiologia e Genetica Medica, Dipartimento di Medicina Sperimentale, Università della Campania Luigi Vanvitelli, Napoli, Italy.

Giacomo P Comi (GP)

Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico, Dino Ferrari Center, , University of Milan, Milan, Italy.

Valeria A Sansone (VA)

The NEMO Center in Milan, Neurorehabilitation Unit, University of Milan, ASST Niguarda Hospital, Milan, Italy.

Emilio Albamonte (E)

The NEMO Center in Milan, Neurorehabilitation Unit, University of Milan, ASST Niguarda Hospital, Milan, Italy.

Alice Donati (A)

Metabolic Unit, A. Meyer Children's Hospital, Florence, Italy.

Enrico Bertini (E)

Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Nathalie Goemans (N)

Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium.

Stefano Previtali (S)

Neuromuscular Repair Unit, Inspe and Division of Neuroscience, IRCSS San Raffaele Scientific Institute, Milan, Italy.

Francesca Bovis (F)

Department of Health Sciences (DISSAL), University of Genova, Genoa, Italy.

Marika Pane (M)

Pediatric Neurology, Università Cattolica del Sacro Cuore, Rome, Italy; Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, Rome 00152, Italy.

Alessandra Ferlini (A)

Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Eugenio Mercuri (E)

Pediatric Neurology, Università Cattolica del Sacro Cuore, Rome, Italy; Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, Rome 00152, Italy. Electronic address: eugeniomaria.mercuri@unicatt.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH